share_log

Oppenheimer Initiates Coverage On Inari Medical With Outperform Rating, Announces Price Target of $75

Oppenheimer Initiates Coverage On Inari Medical With Outperform Rating, Announces Price Target of $75

奥ppenheimer对Inari Medical发起覆盖,给予超出市场表现评级,并宣布目标价为75美元。
Benzinga ·  06:38  · 评级/大行评级

Oppenheimer analyst Steve Lichtman initiates coverage on Inari Medical (NASDAQ:NARI) with a Outperform rating and announces Price Target of $75.

Oppenheimer 分析师Steve Lichtman 开始对Inari Medical (纳斯达克:NARI)进行覆盖,给予"跑赢大盘"评级,并宣布目标价格为75美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发